This Solicitation opportunity from Department Of Defense was posted on June 25, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
DoW Neurofibromatosis Exploration-Hypothesis Development Award
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The fiscal year 2026 Neurofibromatosis Research Program Exploration-Hypothesis Development Award (EHDA), solicitation number HT942526NFRPEHDA, is issued by the Defense Health Agency to support innovative, high-risk, and high-gain research into neurofibromatosis. The program seeks projects with well-formulated, testable hypotheses that address critical needs in areas such as NF2- and schwannomatosis-related research, biomarker discovery, data science, non-tumor manifestations, and drug discovery. Approximately 1.28 million dollars is allocated to fund about eight awards, with each award capped at 160,000 dollars for a maximum period of performance of two years. The application process is a two-step requirement involving a pre-application Letter of Intent submitted via eBRAP by September 8, 2026, followed by a full application due by September 22, 2026, via eBRAP or Grants.gov. Evaluation follows a two-tier process: a first-tier peer review for technical merit and a second-tier programmatic review for relevance to FY26 NFRP priorities. Key evaluation factors include personnel expertise, budget appropriateness, the scientific environment, and application clarity. Applicants must maintain active registrations in SAM.gov, eBRAP.org, and Grants.gov, and must disclose all foreign affiliations of key personnel to comply with national security requirements. Final deliverables include technical progress reports following RPPR standards and an award expiration transition plan.
General Info
Place of Performance
Not specifiedSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
Distinctive Features:
• Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities.
• Preliminary Data: Preliminary and/or published data is encouraged but not required.
More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
